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Background: Drug-eluting stents (DES) were initially used 'on-label' in simple
lesions and low-risk patients. Contemporary second-generation DES are more often
used in 'off-label' settings, while there is limited knowledge about the potential
increase in event risk.
Methods: We analyzed the 2-year clinical outcome data of 1387 TWENTE trial
patients treated with liberal off-label use of second-generation everolimus-eluting
Xience V or zotarolimus-eluting Resolute stents. Periprocedural myocardial infarction
(PMI) was deﬁned as myocardial infarction (MI) 48 hours following PCI. MI was
deﬁned as 2x the upper reference limit of creatine kinase (CK).
Results: Off-label patients (n¼1033; 74.5%) had more diabetes (22.9% vs. 17.5%;
p<0.05), previous MI (35.9% vs. 22.3%; p<0.05), complex lesions (76.1% vs.
60.7%; p<0.05), and acute coronary syndromes (57.8% vs. 33.3%; p<0.05). There
was a higher incidence of periprocedural MI in off-label patients (5.0% vs. 1.4%;
p<0.05), of whom merely 1.1% developed creatine kinase levels >5x ULN.
Consequently, target vessel-related MI was higher in off-label patients (6.4% vs.
2.8%; p<0.05). Nevertheless, cardiac death and target vessel revascularization rates
were similar for both groups (p>0.8).
Conclusions: Patients with off-label DES use had more periprocedural MI. Despite
a higher risk proﬁle and a higher rate of periprocedural MI, 2-year clinical outcome
did not differ from that of patients with on-label DES use. Our ﬁndings underline the
favorable safety proﬁle of these second-generation DES in off-label settings.TCT-343
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Background: The National Cardiovascular Data Registry (NCDR) bleeding risk score
model was derived from a predominantly Caucasian population, with an under-rep-
resented African American (AA) population of 6%. Differential post-PCI bleeding
rates have been reported. We aim to analyze the post-PCI bleeding rates in a better-
represented AA population.
Methods: From our own PCI registry, bleeding (deﬁned by NCDR CathPCI registry
as transfusion, prolonged hospital stay and/or drop in hemoglobin >3g/dL) rates were
compared between AA and non-AA patients. A logistic regression model was used to
compare the accuracy of the NCDR risk score in predicting post-PCI bleed in AA and
non-AA patients, and a net reclassiﬁcation improvement (NRI) analysis was used to
determine if the model's predictive ability was enhanced by adding AA race as
a variable.
Results: A total of 22438 PCI patients were evaluated, of which 6396 (28.5%) were
AA. Although NCDR bleeding risk score was higher in AA than in non-AA [median
(IQR) 13 (8-18) vs 11 (6-17), p <0.001], overall observed bleeding event rates were
similar (5.0% vs. 5.6%, p¼NS). Observed bleeding event rates across risk scores areJACC Vol 62/18S1/Suppl B j October 27–November 1, 2013 j TCT Abpresented in Figure 1. The NCDR model predicted post-PCI bleeding similarly in AA
and non-AA (AUC 0.68 vs 0.72, p¼0.09) (Figure 2), and the model's predictability
was not enhanced by adding AA race as a variable using NRI analysis (NRI 4.8%,
p¼0.20).
Conclusions: The predicted post-PCI bleeding risk was higher in AA compared to
non-AA; however, observed bleeding rates were similar. The NCDR bleeding risk
score remained predictive of post-PCI bleed in both groups.TCT-344
Contrast-induced nephropathy in patients undergoing primary percutaneous
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Background: Contrast-induced nephropathy (CIN) is the third leading cause of acute
renal failure in hospitalized patients and has a negative prognostic impact with
increased mortality and hospital stay. The incidence of CIN in patients undergoing
primary percutaneous coronary intervention (PCI) is higher than in programmed
procedures. In primary PCIs, CIN prevention measures are less applied than in pro-
grammed PCIs. Aim: to analyze CIN in patients undergoing primary PCI and the role
of hydration in its prevention.
Methods: 204 patients (62.813.8 years; 73.5% male) with STEMI who underwent
primary PCI were randomly assigned to receive either hydration with normal saline:
1ml/kg/hour since the beginning of the procedure and 24 hours after it (SS group) or
not (NS group). CIN was deﬁned as a 25% or 0.5 mg/dL increase in serum creatinine
 within 48-72 hours following the procedure.
Results: 41.2% had hypertension, 23.4% diabetes mellitus, 13.3% renal dysfunction
and 15.9% anemia. Mean contrast volume used was 168  69 cc. There were no
signiﬁcant differences between the two groups regarding baseline features, apart from
the higher contrast volume used in the SS group (180 vs 157 cc; p¼0.023). 101
patients (49.5%) were included in SS group and 103 (50.5%) in NS group. We per-
formed an intention to treat analysis with 26% of crossover between groups. CIN was
observed in 17 patients (8.7%): 13 in the NS group and 4 in the SS group (p¼0.028).
Two of these patients needed extrarenal depuration measures. The other predictors of
CIN in the univariate analysis were the higher volume contrast used (217 vs 169 cc;
p¼0.021), the higher age (73.06 vs 62.01; p¼0.001) and the lower hemoglobin prior
the procedure (12.95 vs 14; p¼0.04). In the multivariate analysis, the only predictors
of CIN were the hydration (SS group): OR¼0.19 (0.05-0.69), p¼0.012 and the
contrast volume used: OR¼1.008 (1-1.015), p¼0.04.
Conclusions: Even having received higher doses of contrast, the patients who
received hydration during primary PCI (SS group), reduced by 53% the incidence of
CIN. Given the higher incidence of CIN in emergent procedures, and the morbidity
that it implies, we should improve prevention measures in these patients.
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Background: Entrapment of an intravascular ultrasonography (IVUS) catheter is
a rare but life-threatening complication of percutaneous coronary intervention (PCI).
There is a paucity of data on frequency and treatment of entrapment of an IVUS
catheter.
Methods: We retrospectively reviewed a total of 1852 consecutive patients (2096
lesions) who underwent PCI using 2351 stents (PtCr-EES, n ¼ 1224, 52.1%; BES n
¼ 749, 31.9%; CoCr-EES, n ¼ 148, 6.3%; ZES, n ¼ 92, 3.9%; SES, n ¼ 9, 3.8%;
PtCr-PES, n ¼ 5, 0.2%; BMS, n ¼ 124, 5.3%) in our hospital from June 2012 to
May 2013. Of those, we use an IVUS catheter in 1610 patients (87.1%, 1802
lesions). IVUS catheter included View IT (Terumo, n ¼ 1771, 98.3%), iLAB
(Boston Scientiﬁc, n ¼ 17, 0.9%), Volcano (Volcano, n¼ 8, 0.4%), and others (n ¼ 5,
0.3%).
Results: During the study period, entrapment of an IVUS catheter at the stented lesion
occurred in 10 lesions (0.6%, 13 stents). There was no signiﬁcant difference in the
stent (PtCr-EES n ¼ 10, BES n¼ 3) and IVUS catheter (View IT n ¼ 10). Of those,stracts/POSTER/PCI Complications B109
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technique in one lesion; and retrieved after the imaging core was removed in 5 lesions.
In these 5 lesions, (1) we cut only the outer envelope of View IT catheter; (2) removed
the imaging core (3) put the distal part of 0.014 inch coronary guidewire into the
envelope; and (4) pulled the IVUS catheter. Stent deformation was angiographically
observed in 5 lesions (forcibly extracted in 3 lesions, removed the imaging core in 2
lesions), and post stent dilatation was performed in 6 lesions. All patients with IVUS
entrapment were successfully managed percutaneously and discharged without any
other complication including stent thrombosis.
Conclusions: Entrapment of an IVUS catheter was an infrequent complication of PCI.
Removing imaging core was an alternative technique to retrieve an entrapped IVUS
catheter.
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AMI and ACUITY Trials
Mahesh V. Madhavan1, Giora Weisz1, Michael T. Caton1, Philippe Genereux1,
Ke Xu2, Bernhard Witzenbichler3, Roxana Mehran4, Gregg Stone1
1Columbia University Medical Center and the Cardiovascular Research Foundation,
New York, NY, 2Cardiovascular Research Foundation, New York, NY, 3Charité
Campus Benjamin Franklin, Berlin, Germany, 4Mount Sinai Hospital, New York, NY
Background: Few studies have assessed outcomes in minorities undergoing percu-
taneous coronary intervention (PCI) for acute coronary syndromes (ACS), and
minorities have traditionally been underrepresented in clinical trials in the drug-eluting
stent era. We therefore sought to compare short- and long-term outcomes between
non-white and white patients undergoing PCI for ACS in the large-scale HORIZONS-
AMI and ACUITY trials.
Methods: Data from 11,126 patients undergoing PCI for STEMI and NSTEACS from
the HORIZONS-AMI and ACUITY trials were pooled. Patients were stratiﬁed by race
(non-white vs. white), and adverse outcomes were assessed with propensity-adjusted
multivariable analysis at 30-day and 1-year time points.
Results: Among the total PCI cohort, 10,128 patients (91%) were white and 998
patients (9.0%) were non-white. Non-white patients were younger, more likely to be
women, diabetic, hypertensive, and to have experienced prior myocardial infarction
and coronary revascularization. When controlling for these and other baseline and
treatment variables through propensity-adjusted multivariable analysis, non-white
patients had comparable risk for hemorrhagic and ischemic events compared with
white race counterparts at 30 days and 1 year (Table).
Conclusions: In this analysis of the large-scale HORIZONS-AMI and ACUITY trials,
non-white patients were younger, but otherwise more likely to present with a number
of comorbidities. After propensity-adjustment, non-white patients experienced similar
short- and long-term rates of adverse events as compared with white patients. Further
studies are indicated to help determine whether differences in outcomes between races
reported in the literature are due to baseline risk factors or disparities in access and
treatment.Table. Propensity-Adjusted Adverse Outcomes by Non-White vs. White
Patients
Non-White
Patients
(N=998)
White Patients
(N=10128)
Adjusted Hazard
Ratio
[95% CI]
Adjusted
p-Value
Thirty-Day Outcomes
Non-CABG major
bleeding
72 (7.3) 618 (6.1) 1.16 [0.84, 1.61] 0.36
Transfusion 41 (4.1) 276 (2.7) 1.18 [0.76, 1.82] 0.46
Retroperitoneal
bleed
10 (1.0) 50 (0.5) 1.30 [0.52, 3.23] 0.58
All-cause death 14 (1.4) 150 (1.5) 1.20 [0.50, 2.94] 0.68
Myocardial
infarction
64 (6.5) 484 (4.8) 1.30 [0.96, 1.75] 0.09
Death or
myocardial
infarction
75 (7.6) 602 (6.0) 1.28 [0.95, 1.72] 0.10
MACE 85 (8.6) 715 (7.2) 1.22 [0.93, 1.61] 0.16
One-Year Outcomes
All-Cause death 39 (4.1) 342 (3.8) 1.35 [0.83, 2.17] 0.23
Myocardial
infarction
90 (9.3) 724 (7.5) 1.19 [0.91, 1.56] 0.21
Death or
myocardial
infarction
121 (12.4) 993 (10.5) 1.19 [0.93, 1.52] 0.16
MACE 167 (17.3) 1506 (15.9) 0.98 [0.79, 1.22] 0.87
Data presented as n (%). CABG ¼ coronary artery bypass graft; CI ¼ conﬁdence interval;
MACE ¼ Major Adverse Cardiovascular Events.
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The Efﬁcacy of cystatin C based glomerular ﬁltration rate in the estimation of
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Background: The risk of contrast-inducednephropathy (CIN) is signiﬁcantly inﬂuenced
by baseline renal function and amount of contrast media (CM). Despite commonly usage
in clinical practice, serum creatinine has signiﬁcant limitations in accuracy. Therefore
we evaluated the usefulness of the cystatin C (CyC) based estimated glomerular ﬁltra-
tion rate (eGFRCyC) in prediction of CIN and to determine safe CM dose.
Methods: We prospectively enrolled a total of 723 patients who received percuta-
neous coronary intervention (PCI) and investigated clinical factors associated with
development of CIN. Renal function was calculated as eGFRCyC and a modiﬁed diet
in renal disease (MDRD) equation, respectively. Systemic exposure of CM was
calculated as CM volume to eGFR ratio. We conducted a regression analysis to
evaluate the predictive role of CM volume to eGFRCyC for risk of CIN.
Results: The incidence of CIN was 4.0% (29/723). The patients with CIN had lower
hemoglobin level, more decreased renal function, and higher CyC value, and greater
CM exposure. On multivariate regression analyses, hemoglobin (Odds ratio (OR)
0.743, p¼0.032), CM volume/eGFRCyC (OR 1.697, p¼0.006) and CM volume/
MDRD (OR 2.275, p<0.001) were found to be independent predictors for CIN. In
receiver operating characteristic curve analysis, fair discrimination for CIN was found
at a CM volume/ eGFRCyC level of 4.493 (C-statics ¼ 0.814), and at this value, the
sensitivity and speciﬁcity were 79.3% and 80.0%, respectively.
Conclusions: Thesedata suggest that aCMvolume/eGFRCyCmethodwouldbea simple,
useful indicator for determining the safe CM-dose based on eGFR value before PCI.
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Background: Stroke is a rare complication from percutaneous coronary intervention
(PCI) and is usually associated with high morbidity and mortality. This study was
conducted to review the contemporary incidence and predictors of peri-procedural
stroke related to PCI.
Methods: A total of 23,117 patients who underwent PCI from 2002 to 2012 in our
center were analyzed.
Results: A total of 64 patients suffered with PCI-related stroke. Overall, the rates of
stroke remained constant over the past 10 years (p¼0.09) with an incidence of peri-
procedural stroke per year of 0.24%  0.15%. Patients with stroke were older (69 
11 vs 65  13 years), were more African American (46.2% vs 28.0%), had more
myocardial infarction during admission (54.7% vs 29.8%), more insulin dependent
diabetes mellitus (41.5% vs 35.9%) and more history of chronic kidney disease (25%
vs 15.3%), compared to those without stroke (all p <0.05). Multivariable logistic
analysis identiﬁed IABP as the strongest predictor for stroke, followed by African
American race, presentation with myocardial infarction and increasing age. (Figure)
For patients with peri-procedural stroke, the in-hospital length of stay was longer (12
 11.3 vs 3.1  4 days, p <0.001) and with higher in-hospital mortality (29.2% vs
1.4%, p <0.001), compared to those without stroke.
Conclusions: The rates for PCI-related stroke were low and have remained stable over
the last decade. However, for complex patients requiring IABP, closer stroke miti-
gation strategies should be considered.er 27–November 1, 2013 j TCT Abstracts/POSTER/PCI Complications
